SOCIETY SESSION: BDA. NEW ONCOLOGY DRUGS – APPROVAL PROCESS AND REIMBURSEMENT SYSTEMS IN EUROPE

Conclusions and perspectives

F. Pignatti

Conclusions and perspectives

F. Pignatti

Please set the zoomlevel of your browser to 100%.